logo
Australian swimming legend Michael Klim opens up on devastating battle with rare autoimmune disorder and symptoms he wishes he hadn't ignored

Australian swimming legend Michael Klim opens up on devastating battle with rare autoimmune disorder and symptoms he wishes he hadn't ignored

Daily Mail​17 hours ago

Michael Klim has revealed details about his five-year battle with a rare autoimmune disorder which left him unable to walk - and the symptoms he wishes he took more seriously.
The Aussie swimming legend, 47, was diagnosed with the neurological disorder chronic inflammatory demyelinating polyneuropathy (CIDP) in 2020.
The former triple Olympian has spoken openly about the challenging diagnosis, which saw him lose the ability to walk in just six months and left him bedridden.
He says he didn't treat the condition with the gravity it deserved when he first got symptoms.
'I neglected a lot of my symptoms at the onset and I think in a very typical male fashion didn't act fast enough,' he told News Corp.
'So, if anything comes out of our chat, I hope it's going to see a doctor even if the symptoms are as simple as getting cold feet when you go to bed or having numbness in your toes or your feet. I neglected some of those.
'I had a great team around me but something that was instilled in me as an athlete was that we push through a lot of our discomforts and I continued to do that even in life after sport, which didn't really lend itself to longevity in life.
'Unfortunately, I had my very heart stop when I lost the ability to walk and I think it took me about two years to come to terms with accepting the fact - or almost, it was like there was a grieving period of two years of accepting the fact that my physical ability may never be the same, I may never be able to walk like a normal person, I will be compromised.
'But finding a new purpose in life - I was always very driven and active and very quantitative in that I was very opportunistic and attending many things and being involved in many projects.
CIDP causes the body to attack its own tissue - the myelin sheaths which insulate and protect the nerves - causing weakness and lack of feeling in the arms and legs.
Klim says batting the disorder has taught him a lot.
'There was a lot of time of darkness because there is no cure and you're living in a period of uncertainty - not just yourself as a patient, but your entire support network.
'That was the hardest thing. Previously, my injuries - if I had a rotator cuff injury or sprained ankle - I knew the protocol and knew exactly when I'd be back.
'But this has been something different and something new and it's definitely taught me a lot of lessons.'
Klim says his rare condition has made him more aware of other people and what they might be going through.
'Let's say 30% of people with CIDP may make a full remission, 30% - where I seem to be fitting at the moment - remain stagnant for the rest of their life, and then 30% of people end up with paralysis, full paralysis or in a wheelchair.
'Even when I wear my braces and I've got my pants on, most people look at me and say, "Gee, you're so fit".
'I've got my upper body and am still trying to look after myself, but you just don't know what hardship people are going through underneath.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why Dr Paris uses her bare arms in the fight against Australia's mosquito-borne diseases
Why Dr Paris uses her bare arms in the fight against Australia's mosquito-borne diseases

The Guardian

time4 hours ago

  • The Guardian

Why Dr Paris uses her bare arms in the fight against Australia's mosquito-borne diseases

Dr Véronique Paris has a very hands-on approach to her research. She slides her bare arm inside a special cage and lets hundreds of mosquitoes bite her – all in the name of science. 'For most of the ones I feed, I just feel a little sensation,' the University of Melbourne medical entomologist says. 'Some species do have a bit more of a mechanical feel to them.' Sign up for Guardian Australia's breaking news email She describes the buzzing cage of mosquitoes as her 'colony', and 'to make sure they stay healthy' Paris feeds them her blood about once a week. 'If I am running an experiment or want to collect more eggs for upcoming work, this can increase to about four times a week.' Her research is focused on reducing the transmission of mosquito-borne diseases to humans, such as the flesh-eating Buruli ulcer – that if untreated can cause disfiguration and tissue loss. Paris enjoys sharing her work – and methods – with her community of 13,000 followers on Instagram. The 35-year-old says she moved to Instagram and away from professional social media platforms such as LinkedIn, or even Bluesky, to 'reach people that are not necessarily already looking for scientific content'. '[It] has been very rewarding and there are lots of people that ask lots of questions,' she says. Paris's interest in mosquito research began when she started her PhD at the University of Melbourne, after moving to Australia from Germany. 'I wanted to do something for the local community and understand local mosquitoes [and] locally transmitted diseases like Ross River virus and Buruli ulcer.' Cases of Buruli ulcer have risen sharply in recent years, from 135 in 2020 to 238 in late 2023, according to the Victorian Department of Health. The disease, which is spreading across Victoria, is also found in far north Queensland and the Northern Territory. While possums have long been suspected to play a role in the spread of Buruli ulcer, a 2024 study provided the first strong evidence linking mosquitoes to its transmission. Paris and other researchers are trying to find out how exactly mosquitoes acquire and transmit the pathogen to humans. Sign up to Breaking News Australia Get the most important news as it breaks after newsletter promotion Paris said she was shocked when she first saw her scientific colleagues feeding the insects their blood. 'I was planning big experiments and wanting to have my own mosquito colony, so I felt like I wanted to try it at least once to see if that is something that I can do.' Now it's a part of her weekly lab routine. 'My body has certainly adapted to it … I can feed a cage of mosquitoes and then it's itchy right after, and then I need to be good about not scratching, so I distract myself for about an hour.' Researchers feeding their own colonies is not compulsory, Paris says. 'There will always be volunteers around that can do that, so no one has to feed mosquitoes if they don't want to and that's totally fine.' But outside the lab, getting involuntarily bitten by mosquitoes is a completely different story. Paris says if a mosquito bites her on the ankle while she's in the garden, it might itch for days. Each bite is different, depending on the location on her body and the species of mosquito doing the biting, she says. There are about 300 species of mosquitoes in Australia, how much they itch depends on the person they bite, she explains, adding that the bump and itch is caused by someone's immune response to the bite, so it very person specific. Her top tip? Don't scratch the bite as it only makes the itching worse.

Australia risks losing ‘war on nicotine' in same way as war on drugs as illegal tobacco sales explode
Australia risks losing ‘war on nicotine' in same way as war on drugs as illegal tobacco sales explode

The Guardian

time4 hours ago

  • The Guardian

Australia risks losing ‘war on nicotine' in same way as war on drugs as illegal tobacco sales explode

Australia is now waging a 'de facto war on nicotine' that is doomed to fail in the same way as previous prohibition-style policies, experts say, amid a growing debate about how to respond to an explosion in the illicit tobacco trade. As health experts warn against changes that would undermine decades of fighting to bring down smoking rates, James Martin, a criminology lecturer at Deakin University, and Edward Jegasothy, an epidemiologist at the University of Sydney's School of Public Health, have called for a major overhaul in how we tax tobacco and regulate vaping products. They argue that unaffordable legal cigarettes and an effective ban on retail e-cigarette sales are responsible for the explosion in black market trade for both products. 'Australia's current strategy may be creating more harm than it mitigates, mirroring many of the unintended consequences historically associated with drug prohibition,' Martin and Jegasothy wrote recently in Harm Reduction Journal. Plain packaging, health warnings, restrictions on how smokes are displayed, and education about the dangers of cigarettes have all helped lower smoking rates in recent decades. The gains were hard-fought, particularly against fierce opposition from the tobacco industry, and have garnered global praise. The treasurer, Jim Chalmers, and health minister, Mark Butler, have dismissed calls from the states to lower the tobacco excise, insisting that greater enforcement, rather than cheaper cigarettes, is the answer to squashing the illicit trade. Sign up for Guardian Australia's breaking news email But with Australian cigarettes the most expensive in the world and crime associated with illicit tobacco and vapes rising, Martin said that Australian health authorities should move towards a 'harm reduction' approach. Such an approach would include removing the tobacco excise for a period, and making vapes more available as a recognised smoking cessation tool, alongside other demand-focused policies such as more investment in education. 'Look at the war on drugs; there is something worse than the tobacco industry, and that's the black market,' Martin said. Between 2019 and 2023, Australia experienced its steepest drop in smoking rates in the past 30 years, with the share of adults smoking falling from 11.6% to 8.8%. Martin said it was no coincidence that these years were also when more people were using e-cigarettes. 'Vaping isn't risk-free, but we need to consider its risk vis-a-vis the risks of smoking,' he said. 'Here we have a harm reduction product that many smokers prefer.' Sign up to Breaking News Australia Get the most important news as it breaks after newsletter promotion But the University of Sydney's Becky Freeman, one of the country's leading experts on tobacco control, said she has been frustrated by those calling for radical changes despite a lack of up-to-date and reliable data. 'We want to make sure the growth in the illicit trade isn't undermining tobacco control,' Freeman said. 'If we see any increases in smoking that would be very alarming. 'Freezing tobacco taxes at the moment makes sense – until we get enforcement sorted out there's no point in putting in extra taxes. But that's quite different from rolling it back.' Freeman said that limiting sales of nicotine vapes to pharmacies was 'not a big ask for a product that is highly addictive and dangerous'. 'They are not a consumer good,' she said. 'We made this mistake with tobacco products, why would we turn around and do the same thing with vapes?' Freeman said youth vaping rates in Australia were lower than in New Zealand, the UK and Canada, which allow the retail sale of e-cigarettes, and that new licensing requirements for tobacconists in New South Wales and Victoria were 'long overdue'. 'We have done an excellent job on demand reduction,' she said. 'We haven't controlled supply that well at all.'

EXCLUSIVE 'Miracle' side effect of common cosmetic procedure could help millions of Australians - but it'll set you back thousands
EXCLUSIVE 'Miracle' side effect of common cosmetic procedure could help millions of Australians - but it'll set you back thousands

Daily Mail​

time12 hours ago

  • Daily Mail​

EXCLUSIVE 'Miracle' side effect of common cosmetic procedure could help millions of Australians - but it'll set you back thousands

More Aussies are splashing the cash for Botox, but the trend isn't just for facial slimming, it's also helping sufferers of a painful medical condition. Nearly five million Australians experience migraines with 7.6 per cent of patients struggling with the debilitating effects more than 15 days a month, a study by Headaches Australia found. Yet despite costing the economy an estimated $35.7billion per year, patients using a procedure proven to reduce the frequency and severity of migraines need to pay out of pocket. Kate Sowden, a nurse and co-founder of Brisbane's BeautyFULL Cosmetic Medical Clinic, has noticed an increase in customers requesting jaw Botox, also known as Masseter Botox, for migraine relief. While she cannot treat migraines, she has noticed that customers who have Botox in their jaw suffer less headaches. 'I first heard about Masseter Botox being associated with migraine relief a few years ago, through both clinical discussions and feedback from patients who noticed their headaches had eased following treatment,' Ms Sowden told Daily Mail Australia. 'Masseter Botox is primarily used to help with jaw tension, teeth grinding and facial slimming, with reports of reduced headache frequency coming as a welcomed side effect.' While Botox is making waves for its medicinal applications, it is still often dismissed as only a cosmetic tool by doctors. 'Awareness has definitely grown in the past 12 to 18 months. Social media, TikTok especially, has played a big role in bringing treatments like Masseter Botox into mainstream conversations,' Ms Sowden said. 'It has helped to move away from the use for aesthetic reasons, to the use for functional benefits. 'Still, many people are surprised to learn that this kind of injectable can potentially help with tension-related symptoms.' Jude Kingston began using Masseter Botox four years ago after suffering an average of one migraine a week. 'Now I get maybe one every six weeks and, for me, the Botox normally lasts about four months,' she told Daily Mail Australia. Despite the success seen in Ms Kingston and several other Masseter Botox patients, the muscle relaxing treatment is not subsidised unless patients see a specialist. 'Cosmetic Botox, including Masseter treatment for jaw tension or aesthetic concerns, is not covered by Medicare or private health insurance in Australia,' Ms Sowden said. 'Only neurologist-administered therapeutic Botox for chronic migraines, offered under specific criteria, may qualify for a Medicare subsidy. 'It's essential that clients seeking medical migraine treatment go through the proper diagnostic channels with a neurologist.' While it's important for patients to ensure they're suited to the treatment, seeing a specialist and meeting the current subsidy criteria is a long and costly process. In order to qualify, patients must have suffered more than 15 days of headache in a month, tried at least three migraine treatments, be managed for medication overuse headache, treated by a neurologist and over 18 years old. Even if they pass eligibility, the Botox must be prescribed and administered by a neurologist. Pricing at Ms Sowden's clinic starts at $400 per session but 'varies based on muscle strength and how many units are required'. The effects of the treatment last between three and five months. 'We've definitely noticed more people enquiring about Masseter Botox in the context of migraines over the past year,' Ms Sowden said. 'Many are either undiagnosed or struggling to find long-term solutions, and come across muscle relaxant options online. 'In a cosmetic clinic like ours, we don't treat migraines medically but we can offer Masseter Botox for clients dealing with jaw clenching, TMJ discomfort, or bruxism.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store